Intravitreal injection of MALAT1 siRNA significantly reduced the degree of retinopathy compared to the OIR control group, leading to decreased protein and mRNA expression levels of CCN1, AKT, and VEGF. This evidence concerns the gene MALAT1 and retinal disorder.